Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis: 3 Treatment Approaches | Clinical Trial - ISAR-DESIRE 3


The optimal treatment of drug-eluting stent (DES) in-stent restenosis (ISR) is not well established. The current trial sought to compare three different strategies for the treatment of DES ISR: 1) treatment with paclitaxel-eluting balloon (PEB), 2) paclitaxel-eluting stent (PES), or 3) balloon angioplasty alone.

Contribution to the Literature: The ISAR-DESIRE 3 trial showed that paclitaxel-coated balloons have similar repeat revascularization rates as PES, but lower than balloon angiop...